These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1035234)

  • 1. [Serum complement in malignant tumors of the head and neck (author's transl)].
    Inuyama Y; Horiuchi M; Nakajima Y; Asaoka K; Yamazaki Y
    Nihon Gan Chiryo Gakkai Shi; 1976 Dec; 11(4):711-9. PubMed ID: 1035234
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological reactivity of patients with malignant tumor of the head and neck. Part 4. Differences in variation of immunological reactivity between operation and radiation (author's transl)].
    Sakaguchi K; Okuda M; Tomiyama S
    Nihon Jibiinkoka Gakkai Kaiho; 1981 Feb; 84(2):129-38. PubMed ID: 7277079
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical assessment of the patients with head and neck cancers using hematological serological and immunological parameters (author's transl)].
    Okamoto M
    Nihon Jibiinkoka Gakkai Kaiho; 1981 Nov; 84(11):1408-23. PubMed ID: 6977628
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum complement levels in patients with head and neck cancer.
    Inuyama Y; Horiuchi M; Kohno N; Mashino S; Yamazaki Y; Ogawa H; Saito S
    Auris Nasus Larynx; 1981; 8(2):65-75. PubMed ID: 7337590
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nonspecific immunological reactivity of patients with malignant tumors of the head and neck].
    Sakaguchi K
    Nihon Jibiinkoka Gakkai Kaiho; 1983 Aug; 86(8):899-911. PubMed ID: 6663383
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cellular immune reactivity in Tumor patients: peripheral blood T-lymphocytes (author's transl)].
    Sesterhenn K; Krueger GR; Uhlmann C
    Laryngol Rhinol Otol (Stuttg); 1977 Oct; 56(10):807-14. PubMed ID: 144215
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological prognostic data in otorhinolaryngologic cancerology].
    Serrou B; Karcenty L; Romieu C
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1972 Dec; 21(10):897-9. PubMed ID: 4265731
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunocompetence of patients with malignant lymphoma (comparative study to that of patients with head and neck cancer) (author's transl)].
    Sakaguchi K; Okuda M; Tomiyama S
    Nihon Jibiinkoka Gakkai Kaiho; 1979 Jul; 82(7):682-8. PubMed ID: 536878
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of changes of complement-system in malignant diseases (author's transl)].
    Kondo I; Kdaira T; Matsuzaki M; Shioda Y; Arita T; Tanaka T; Kayama J; Hasegawa H; Aiba H
    Nihon Gan Chiryo Gakkai Shi; 1978 Aug; 13(4):375-86. PubMed ID: 712166
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of cellular immunity in patients with malignant tumors].
    Niksic M; Balogh M; Jurin M
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(9-10):387-96. PubMed ID: 794967
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological studies on uveitis by "six stages classification after tuberculin reaction and CH50" (author's transl)].
    Kogure M; Ono Y; Shimada K
    Nippon Ganka Gakkai Zasshi; 1977 Aug; 81(8):1092-100. PubMed ID: 930770
    [No Abstract]   [Full Text] [Related]  

  • 12. [Autologous lymphocytotoxicity against squamous cell carcinoma in head and neck. I. In vitro culture of squamous cell carcinoma in head and neck (author's transl)].
    Ikawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1981 Dec; 84(12):1570-8. PubMed ID: 7341742
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our immunological investigations in the cancer of the head and neck (author's transl)].
    Krajina Z; Kosoković F; Kosovski V; Poljak Z
    Lijec Vjesn; 1976 Jan; 98(1):32-4. PubMed ID: 940413
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological reactivity of patients with malignant tumors of the head and neck. Part 3: PHA-induced lymphocyte transformation test (author's transl)].
    Sakaguchi K; Tomiyama S; Okuda M
    Nihon Jibiinkoka Gakkai Kaiho; 1979 Nov; 82(11):1372-80. PubMed ID: 536864
    [No Abstract]   [Full Text] [Related]  

  • 15. [Carcinogen in the development of head and neck cancer (Part 2) --head and neck malignant tumors with alcoholism (author's transl)].
    Miyahara H; Sato T
    Nihon Jibiinkoka Gakkai Kaiho; 1981 Feb; 84(2):146-53. PubMed ID: 7277081
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the serum complement in pulmonary tuberculosis. 2. Tuberculin reaction and serum complement level in pulmonary tuberculosis].
    Emura M
    Arerugi; 1967 Aug; 16(8):522-40. PubMed ID: 5584261
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fibrin and fibrinogen degradation products in head- and neck-tumors (author's transl)].
    Wilmes EH; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1978 Dec; 57(12):1083-6. PubMed ID: 732487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the serum complement in pulmonary tuberculosis. 1. The complement level and serum protein pattern in healthy tuberculin-positive and -negative adults].
    Emura M
    Arerugi; 1967 Aug; 16(8):512-21. PubMed ID: 5584260
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dysproteinemia in malignant tumors of the urogenital system. III. Changes of complement system and proteinase inhibitors in the serum (author's transl)].
    Kondo I; Kodaira A; Tanaka T; Shioda Y; Arita T
    Nihon Hinyokika Gakkai Zasshi; 1978 Mar; 69(3):365-72. PubMed ID: 661043
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is there a role for immunology in the prevention of malignant tumors of the head and neck?].
    Beatrice F; Cortesina G; Succo G; Spiga G; Bessone F; Pecorari G; Sartoris A
    Acta Otorhinolaryngol Ital; 1990; 10 Suppl 27():55-8. PubMed ID: 2203225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.